Lethal midline granuloma

From WikiMD's Medical Encyclopedia

Revision as of 03:17, 11 February 2025 by Prab (talk | contribs) (CSV import)

Lethal midline granuloma is a rare and aggressive condition characterized by the progressive destruction of the tissues in the midline structures of the face, including the nose, sinuses, and palate. This condition is often associated with non-Hodgkin lymphoma, particularly the extranodal NK/T-cell lymphoma, nasal type.

Presentation

Patients with lethal midline granuloma typically present with symptoms such as nasal obstruction, chronic sinusitis, and ulceration of the nasal septum. As the disease progresses, it can lead to severe facial disfigurement, including the destruction of the nasal bridge and palate, resulting in oronasal fistulas.

Pathophysiology

The exact cause of lethal midline granuloma is not well understood, but it is believed to be related to an abnormal immune response. The condition is characterized by the presence of atypical lymphoid cells, which are often positive for Epstein-Barr virus (EBV). These cells infiltrate and destroy the tissues in the midline structures of the face.

Diagnosis

Diagnosis of lethal midline granuloma involves a combination of clinical evaluation, imaging studies, and biopsy. Computed tomography (CT) and magnetic resonance imaging (MRI) can help assess the extent of tissue destruction. A biopsy of the affected tissue is essential to confirm the diagnosis and to differentiate it from other conditions such as Wegener's granulomatosis and sarcoidosis.

Treatment

The treatment of lethal midline granuloma typically involves a combination of radiotherapy and chemotherapy. Early diagnosis and treatment are crucial to prevent extensive tissue destruction and to improve the prognosis. In some cases, surgical intervention may be necessary to repair the damaged structures and to restore function.

Prognosis

The prognosis for patients with lethal midline granuloma varies depending on the stage at which the disease is diagnosed and the response to treatment. Early-stage disease has a better prognosis, while advanced disease with extensive tissue destruction is associated with a poorer outcome.

Related Pages


Stub icon
   This article is a hematology stub. You can help WikiMD by expanding it!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?

Get started with evidence based, physician-supervised

affordable GLP-1 weight loss injections

Now available in New York City and Philadelphia:

✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends

Learn more:

Start your transformation today with W8MD weight loss centers.

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.